11. Science. 1923-1994.
This section has been divided into fifteen thematic sub-sections, which, when taken as a whole, reflect the extraordinary breadth of Linus Pauling's scientific biography. Boxes in the Science section typically hold manuscripts, research notes, correspondence, figures, experimental data, non-Pauling reprints and other scientific research materials. Generally speaking, materials have been arranged and cataloged according to research topic. However, two sub-sections reflect the institutional architecture either supporting or directing Pauling's work during specific periods of his life. For example, the bulk of the collection's holdings concerning Pauling's relationship with the American Chemical Society have been cataloged under the rubric "Scientific, Research and Grant-Funding Institutions." A similar approach has been taken with much of Pauling's work sponsored by the Guggenheim Foundation, Rockefeller Foundation, Ford Foundation, etc.
221 boxes
11. Orthomolecular Medicine.
Boxes 11.061 - 11.070 (Page: 61 - 70)
11.061.
Materials re: the use of orthomolecular medicine as a treatment for cancer.
61.1.
Articles and Reprints: Scientific reports of orthomolecular cancer treatment.
61.2.
Articles and Reprints: Popular reports of orthomolecular cancer treatment.
61.3.
Articles and Reprints: Research reports of orthomolecular cancer treatment.
61.4.
Articles and Reprints: B-vitamins and cancer.
61.5.
Articles and Reprints: Vitamin B17 and cancer.
61.6.
Articles and Reprints: Asparagus/asparagine cancer therapy.
61.7.
Articles and Reprints: Beta carotene and cancer reduction.
61.8.
Articles and Reprints: Hydrazine sulfate and cancer therapy.
61.9.
Articles and Reprints: Hypothermia and cancer.
61.10.
Articles and Reprints: Nitrolosides and cancer.
61.11.
Articles and Reprints: Selenium and cancer resistance.
61.12.
Articles and Reprints: Miscellaneous diet and cancer.
61.13.
Articles and Reprints: Cancer prevention and policy information.
61.14.
Publication, Correspondence: A Matter of Life and Death: The Incredible Story of Krebiozen, Bailey, Herbert, New York: MacFadden Books, 1964.
61.15.
Typescript: Diet, environment, and cancer, Scott Stirling, No Date.
61.16.
Manuscript Notes re: the structure of Canavanine and its chemotherapeutic uses, 1970.
61.17.
LP Grant Application: Antitumor activity of neocarzinostatin peptides, 1973.
11.062.
Assorted Materials re: chelation therapy.
62.1.
Book Cover: "Chelation Therapy" by Dr. Morton Walker.
62.2.
Typescripts: The Question and Answer of Chelation Therapy for Generalized Cardiovascular Atherosclerosis, by McGuff Clinic, No Date; and No Title [EDTA therapy protocol], Author Unknown, No Date.
62.3.
Documents re: EDTA and calcium disodium versenate, published by the Food and Drug
Administration, No Date.
62.4.
Articles and Reprints: General discussion of chelation therapy.
62.5.
Articles and Reprints: Chelation therapy and atherosclerosis.
62.6.
Articles and Reprints: Chelation therapy and miscellaneous vascular disorders.
62.7.
Articles and Reprints: Chelation therapy and brain disorders.
62.8.
Articles and Reprints: Miscellaneous effects of chelation therapy.
11.063.
Assorted Materials re: chelation therapy, 1964-1987.
63.1.
Publication: Chelation Therapy, Alfred Soffer, et al., Springfield, Illinois: Thomas Books, 1964.
63.2.
Typescripts: Clinical Results of Chelation Therapy on 100 Cardiovascular Patients at Meadowbrook
Hospital, Belle Chasse, Louisiana, Ray Evers, 1976; and Clinical Results of Evers I.V. Solution on 100 Cardiovascular Patients at Ra-Mar Clinic,
Montgomery, Alabama, Ray Evers, 1980.
63.3.
Correspondence re: EDTA chelation therapy, 1979-1985.
63.4.
Assorted Articles and Reprints re: EDTA chelation therapy, 1970s.
63.5.
Transcripts: Protocol for Use of E.D.T.A. Chelation Therapy in Arteriosclerosis for Members of
the American Academy of Medical Preventics, American Academy of Medical Preventics, 1982.
63.6.
Typescript: A Retrospective Thermographic Study of Patients Undergoing Intravenous Chelation Therapy, Cypher Corporation, Inc., 1986. [Includes additional materials re: Project Cypher].
63.7.
EDTA Chelation Therapy in Chronic Degenerative Disease, Efrain Olszewer and James P. Carter, 1987.
63.8.
Articles: E. Cheraskin on EDTA chelation therapy, 1980s.
63.9.
Articles and Reprints re: chelation therapy, by David J. Spence, 1980s.
11.064.
Materials re: Laetrile, 1971-1986.
64.1.
Correspondence re: Laetrile, 1971-1986.
64.2.
Publication: "Laetrile - Commissioners Decision on Status", Federal Register, Food and Drug Administration, August 5, 1977.
64.3.
Affidavits: from FDA rulemaking proceedings concerning laetrile, September 29, 1977.
64.4.
LP Notes, Correspondence and Reprints re: Laetrile studies conducted by the Sloan-Kettering
Cancer Center, 1977-1978.
11.065.
Articles and Reprints re: Laetrile.
65.1.
Correspondence, Articles, Reprints re: Various uses of Laetrile.
65.2.
Correspondence, Articles, Reprints re: Vitamin B17 and Laetrile.
65.3.
Articles and Reprints re: Anti-tumor activity of amygdalin.
65.4.
Articles and Reprints re: Ineffectiveness and/or adverse effects of Laetrile, No Date.
11.066.
Orthomolecular medicine materials related to vitamin A.
66.1.
Articles and Reprints: Vitamin A, 1935-1969.
66.2.
Correspondence, Articles, Reprints: Vitamin A, 1970-1979.
66.3.
Assorted Materials re: Hypervitaminosis A symptoms, No Date.
11.067.
Orthomolecular medicine materials related to vitamin B1, No Date.
67.1.
Articles and Reprints: Vitamin B1, 1937-1976.
11.068.
Orthomolecular medicine materials related to vitamin B2, 1938-1976.
68.1.
Articles and Reprints: Vitamin B2, 1938-1976.
11.069.
Orthomolecular medicine materials related to vitamin B3, 1939-1979.
69.1.
Articles and Reprints: Vitamin B3, 1939-1969.
69.2.
Articles and Reprints: Vitamin B3, 1970-1979.
11.070.
Orthomolecular medicine materials related to vitamin B6, 1935-1981.
70.1.
Articles and Reprints: Vitamin B6, 1935-1969.
70.2.
Notes, Articles and Reprints: Vitamin B6, 1970-1981.
< Previous Page
51-60. 11.051 - 11.060.
51-60. 11.051 - 11.060.
Next Page >
71-80. 11.071 - 11.080.
71-80. 11.071 - 11.080.